National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Dictionary of Cancer Terms
Send to Printer
bevacizumab (beh-vuh-SIH-zoo-mab)

 A monoclonal antibody used in the treatment of colorectal cancer that has spread. It is also being studied in the treatment of other types of cancer. Bevacizumab binds to vascular endothelial growth factor (VEGF) and may stop the growth of new blood vessels needed for tumors to grow. It is a type of antiangiogenesis agent. Also called Avastin.

Previous Definitions:beta hemolytic streptococcus group B, beta-2-microglobulin, beta-endorphin, beta-glucan, beta-human chorionic gonadotropin
Next Definitions:bexarotene, Bexxar regimen, BG00001, BI 2536, BI-RADS